Bank Julius Baer & Co. Ltd Zurich Buys New Holdings in Humana Inc. $HUM

Bank Julius Baer & Co. Ltd Zurich acquired a new stake in Humana Inc. (NYSE:HUM - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 3,065 shares of the insurance provider's stock, valued at approximately $1,186,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of HUM. Pinnacle Wealth Planning Services Inc. lifted its holdings in Humana by 21.8% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 151 shares of the insurance provider's stock worth $58,000 after buying an additional 27 shares during the period. Wilkerson Advisory Group LLC increased its stake in shares of Humana by 24.6% during the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider's stock valued at $66,000 after buying an additional 33 shares during the period. Cidel Asset Management Inc. increased its stake in shares of Humana by 1.1% during the second quarter. Cidel Asset Management Inc. now owns 3,883 shares of the insurance provider's stock valued at $1,542,000 after buying an additional 41 shares during the period. Greenleaf Trust raised its holdings in shares of Humana by 1.7% during the third quarter. Greenleaf Trust now owns 2,524 shares of the insurance provider's stock valued at $963,000 after acquiring an additional 41 shares in the last quarter. Finally, Bogart Wealth LLC raised its holdings in shares of Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on HUM shares. Cantor Fitzgerald raised Humana from a "neutral" rating to an "overweight" rating and raised their price target for the stock from $300.00 to $460.00 in a research note on Wednesday, October 7th. Wells Fargo & Company raised shares of Humana from an "equal weight" rating to an "overweight" rating and boosted their price objective for the company from $227.00 to $502.00 in a research report on Monday, July 13th. Wolfe Research restated an "outperform" rating and issued a $450.00 price objective on shares of Humana in a report on Monday, August 24th. Morgan Stanley raised shares of Humana from an "underweight" rating to an "overweight" rating in a research report on Friday, October 9th. Finally, Barclays lifted their target price on shares of Humana from $515.00 to $582.00 and gave the company an "overweight" rating in a research note on Friday, October 9th. Twenty-one equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Humana has a consensus rating of "Moderate Buy" and a consensus price target of $453.30.

Humana Price Performance

HUM opened at $417.32 on Thursday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market cap of $50.11 billion, a price-to-earnings ratio of 24.30, a price-to-earnings-growth ratio of 2.57 and a beta of 0.65. The stock has a fifty day simple moving average of $402.73 and a two-hundred day simple moving average of $310.76. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $456.50.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 24th will be given a $0.8850 dividend. The ex-dividend date of this dividend is Thursday, December 24th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.8%. Humana's dividend payout ratio is currently 33.49%.

Humana Profile

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company's primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.